Adverum Biotechnlgs (NQ: ADVM )
1.490 +0.010 (+0.68%) Streaming Delayed Price Updated: 10:41 AM EDT, Jun 8, 2023 Add to My Watchlist
Headline News about Adverum Biotechnlgs
12 Health Care Stocks Moving In Monday's After-Market Session
November 28, 2022
Adverum Posts New Data From Wet AMD Gene Therapy Trial
July 15, 2022
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Adverum Commences Mid-Stage Chronic Eye Disorder Candidate Study
September 14, 2022
Adverum Biotechnologies (NASDAQ: ADVM) dosed first subject in the LUNA Phase 2 trial evaluating ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022) for the treatment of wet age-related...
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 26, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following